Theriva Biologics, Inc. (TOVX) › Total AssetsTheriva Biologics, Inc. (TOVX) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $4.11M2011: $7.48M2012: $13.42M2013: $16.26M2014: $19.14M2015: $30.84M2016: $22.50M2017: $18.84M2018: $30.14M2019: $17.23M2020: $8.41M2021: $70.36M2022: $71.86M2023: $55.22M2024: $35.35M2025: $38.24M$38.24M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$38.24M+8.2%2024$35.35M-36.0%2023$55.22M-23.2%2022$71.86M+2.1%2021$70.36M+736.7%2020$8.41M-51.2%2019$17.23M-42.8%2018$30.14M+60.0%2017$18.84M-16.3%2016$22.50M-27.1%2015$30.84M+61.1%2014$19.14M+17.8%2013$16.26M+21.1%2012$13.42M+79.5%2011$7.48M+81.9%2010$4.11M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share